Cite
HARVARD Citation
Kao, J. et al. (2018). Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study. Journal of gastroenterology and hepatology. 33 (8), pp. 1507-1510. [Online].